BioXcel Therapeutics (BTAI) Receivables (2019 - 2026)
BioXcel Therapeutics' (BTAI) quarterly Receivables came in at $216000.0 in Q1 2026, down 7.3% quarter-over-quarter from $233000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Receivables (2019 - 2026) Analysis & Trends
BioXcel Therapeutics' Receivables history runs 6 years deep, the most recent figure standing at $216000.0 for Q1 2026.
- On a quarterly basis, Receivables changed N/A year-over-year to $216000.0 in Q1 2026; TTM through Mar 2026 was $216000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $233000.0, up 77.86% from the prior year.
- Receivables retreated to $216000.0 in Q1 2026 per BTAI's latest filing, from $233000.0 in the prior quarter.
- Across five years, Receivables topped out at $812000.0 in Q2 2024 and bottomed at $3000.0 in Q3 2024.
- The 5-year median for Receivables is $240500.0 (2022), against an average of $296500.0.
- Biggest YoY gain for Receivables was 88.4% in 2024; the steepest drop was 99.59% in 2024.
- Year by year, Receivables stood at $248000.0 in 2022, then plunged by 71.37% to $71000.0 in 2023, then soared by 84.51% to $131000.0 in 2024, then surged by 77.86% to $233000.0 in 2025, then fell by 7.3% to $216000.0 in 2026.
- Per Business Quant, the three latest BTAI Receivables figures stand at $216000.0 (Q1 2026), $233000.0 (Q4 2025), and $17000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | BioXcel Therapeutics | 10.62 Mn | 10.62 Mn | -77,000.00 | 216,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Sep 30, 2023 | 735,000.00 |
| Jun 30, 2023 | 431,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Dec 31, 2022 | 248,000.00 |
| Dec 31, 2019 | 82,000.00 |
| Sep 30, 2019 | 173,000.00 |
| Jun 30, 2019 | 468,000.00 |
| Mar 31, 2019 | 291,000.00 |